middle.news

Epiminder Accelerates US Rollout with Strong DETECT Progress and Next-Gen Device on Track

8:33am on Thursday 30th of July, 2026 AEST Healthcare
Read Story

Epiminder Accelerates US Rollout with Strong DETECT Progress and Next-Gen Device on Track

8:33am on Thursday 30th of July, 2026 AEST
Key Points
  • 50 patients enrolled ahead of schedule in DETECT study
  • 20 leading US clinical sites active including Mayo Clinic and Stanford
  • Medicare proposes 14% reimbursement increase for 2027
  • Next-generation Minder device design completion targeted mid-2027
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Epiminder (ASX:EPI)
OPEN ARTICLE